Loading...

Jula Veerapong

Title(s)Associate Clinical Professor, Surgery
SchoolHealth Sciences
Phone858-534-8116
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lee TC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Ahmed A, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Zaidi MY, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Greer J, Patel SH. Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study. J Gastrointest Surg. 2019 Nov 19. PMID: 31745888.
      View in: PubMed
    2. Wiseman JT, Kimbrough C, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Lee B, Fackche N, Greer J, Pawlik TM, Abdel-Misih S, Cloyd JM. Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter? Ann Surg Oncol. 2019 Oct 28. PMID: 31659645.
      View in: PubMed
    3. Beal EW, Ahmed A, Grotz T, Leiting J, Fournier KF, Lee AJ, Dineen S, Dessureault S, Baumgartner JM, Veerapong J, Clarke C, Strong E, Maithel SK, Zaidi MY, Patel S, Dhar V, Hendrix R, Lambert L, Johnston F, Fackche N, Raoof M, LaRocca C, Ronnekleiv-Kelly S, Pokrzywa C, Pawlik TM, Abdel-Misih S, Cloyd JM. Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg. 2019 Sep 19. PMID: 31558307.
      View in: PubMed
    4. Levinsky NC, Morris MC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Kimbrough C, Fournier K, Lee A, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Zaidi MY, Staley CA, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Ronnekleiv-Kelly S, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Patel SH. Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative. J Gastrointest Surg. 2019 Aug 19. PMID: 31428960.
      View in: PubMed
    5. Baumgartner JM, Marmor R, Hsu A, Veerapong J, Kelly KJ, Lowy AM. Obstruction-Free Survival Following Operative Intervention for Malignant Bowel Obstruction in Appendiceal Cancer. Ann Surg Oncol. 2019 Oct; 26(11):3611-3617. PMID: 31190209.
      View in: PubMed
    6. Khan S, Kelly KJ, Veerapong J, Lowy AM, Baumgartner JM. Incidence, Risk Factors, and Prevention Strategies for Venous Thromboembolism after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 2019 Jul; 26(7):2276-2284. PMID: 31065960.
      View in: PubMed
    7. Kotha NV, Baumgartner JM, Veerapong J, Cloyd JM, Ahmed A, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Dessureault S, Clarke C, Mogal H, Zaidi MY, Russell MC, Patel SH, Sussman JJ, Dhar V, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Greer JB, Fackche N, Lowy AM, Kelly KJ. Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study. Ann Surg Oncol. 2019 Jul; 26(7):2234-2240. PMID: 31016486.
      View in: PubMed
    8. Kelly KJ, Alsayadnasser M, Vaida F, Veerapong J, Baumgartner JM, Patel S, Ahmad S, Barone R, Lowy AM. Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy? Ann Surg Oncol. 2019 May; 26(5):1421-1427. PMID: 30815802.
      View in: PubMed
    9. Panuganti B, Chang ES, Helm CW, Schwartz T, Hsueh EC, Piao J, Lai J, Veerapong J. Cytoreductive Surgery and Normothermic Intraperitoneal Chemotherapy for Signet Ring Cell Appendiceal Adenocarcinoma With Peritoneal Metastases in the Setting of Cirrhosis. Gastroenterology Res. 2018 Jun; 11(3):247-251. PMID: 29915638.
      View in: PubMed
    10. Meeks M, Grace S, Veerapong J, Chen Y, Cao D, Zhou Y, Lai JP. Primary Angiosarcoma of the Pancreas. J Gastrointest Cancer. 2017 Dec; 48(4):369-372. PMID: 27228987.
      View in: PubMed
    11. Lee AA, Poddar N, Hammami MB, Veerapong J, Cao D, Lai JP. Gastric Spindle Cell Neuroendocrine Tumor Mimicking Gastrointestinal Stromal Tumor: Unique Morphology and Diagnostic Pitfall. Anticancer Res. 2017 10; 37(10):5893-5897. PMID: 28982917.
      View in: PubMed
    12. Gray S, Chen Y, Litton T, Jallad B, Poddar N, Hoff JT, Schroeder K, Taylor J, Veerapong J, Lai JP. Synchronous Ileal Neuroendocrine Tumor and Ovarian Steroid Cell Tumor Present in a Female With Hyperandrogenism. Int J Gynecol Pathol. 2016 Nov; 35(6):554-560. PMID: 27167674.
      View in: PubMed
    13. Piao J, Friedman P, Siddiqui S, Veerapong J, Lai JP. Synchronous Type 1 Papillary Renal Cell Carcinoma in a Patient with Rectal Adenocarcinoma. Anticancer Res. 2016 09; 36(9):4821-4. PMID: 27630335.
      View in: PubMed
    14. de Rosa N, Rodriguez-Bigas MA, Chang GJ, Veerapong J, Borras E, Krishnan S, Bednarski B, Messick CA, Skibber JM, Feig BW, Lynch PM, Vilar E, You YN. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. J Clin Oncol. 2016 09 01; 34(25):3039-46. PMID: 27432916.
      View in: PubMed
    15. Schwartz TL, Veerapong J, Hinyard L. Her2 positivity and race predict higher mastectomy rates: a SEER database analysis. Springerplus. 2015; 4:715. PMID: 26636003.
      View in: PubMed
    16. Grace S, Muzaffar R, Veerapong J, Alkaade S, Poddar N, Phillips N, Guzman M, Batanian J, Vogler C, Lai JP. Synchronous quadruple primary neoplasms: glioblastoma, neuroendocrine tumor, schwannoma and sessile serrated adenoma in a patient with history of prostate cancer. Anticancer Res. 2015 Apr; 35(4):2121-7. PMID: 25862868.
      View in: PubMed
    17. Schwartz TL, Mogal H, Papageorgiou C, Veerapong J, Hsueh EC. Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies. Exp Hematol Oncol. 2013 Nov 14; 2(1):31. PMID: 24499560.
      View in: PubMed
    18. Veerapong J, Solomon H, Helm CW. Morison's Pouch peritonectomy in cytoreductive surgery. Gynecol Oncol. 2013 Oct; 131(1):214. PMID: 23863360.
      View in: PubMed
    19. Veerapong J, Solomon H, Helm CW. Division of the pont hepatique of the liver in cytoreductive surgery for peritoneal malignancy. Gynecol Oncol. 2013 Jan; 128(1):133. PMID: 30036927.
      View in: PubMed
    20. Veerapong J, Helm CW, Solomon H. Resection of tumor from the supragastric lesser sac with peritonectomy. Gynecol Oncol. 2012 Oct; 127(1):256. PMID: 22727984.
      View in: PubMed
    21. Veerapong J, Wahlgren CM, Jolly N, Bassiouny H. Successful percutaneous retrieval of an inferior vena cava filter migrating to the right ventricle in a bariatric patient. Cardiovasc Intervent Radiol. 2008 Jul; 31 Suppl 2:S177-81. PMID: 18204951.
      View in: PubMed
    22. Bickenbach KA, Veerapong J, Shao MY, Mauceri HJ, Posner MC, Kron SJ, Weichselbaum RR. Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapy. Cancer Gene Ther. 2008 Mar; 15(3):133-9. PMID: 18157146.
      View in: PubMed
    23. Yamini B, Yu X, Pytel P, Galanopoulos N, Rawlani V, Veerapong J, Bickenbach K, Weichselbaum RR. Adenovirally delivered tumor necrosis factor-alpha improves the antiglioma efficacy of concomitant radiation and temozolomide therapy. Clin Cancer Res. 2007 Oct 15; 13(20):6217-23. PMID: 17947489.
      View in: PubMed
    24. Veerapong J, Bickenbach KA, Shao MY, Smith KD, Posner MC, Roizman B, Weichselbaum RR. Systemic delivery of (gamma1)34.5-deleted herpes simplex virus-1 selectively targets and treats distant human xenograft tumors that express high MEK activity. Cancer Res. 2007 Sep 01; 67(17):8301-6. PMID: 17804745.
      View in: PubMed
    25. Bickenbach K, Wilcox R, Veerapong J, Kindler HL, Posner MC, Noffsinger A, Roggin KK. A review of resistance patterns and phenotypic changes in gastrointestinal stromal tumors following imatinib mesylate therapy. J Gastrointest Surg. 2007 Jun; 11(6):758-66. PMID: 17417711.
      View in: PubMed
    26. Smith KD, Mezhir JJ, Bickenbach K, Veerapong J, Charron J, Posner MC, Roizman B, Weichselbaum RR. Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1. J Virol. 2006 Feb; 80(3):1110-20. PMID: 16414988.
      View in: PubMed